莫西沙星

  • 网络moxifloxacin;Avelox;vigamox
莫西沙星莫西沙星
  1. 目的建立特定培养基中莫西沙星的HPLC测定法。

    OBJECTIVE To develop a HPLC method for the determination of moxifloxacin in special growth media .

  2. 莫西沙星治疗COPD患者合并肺炎的疗效

    Effect of Moxifloxacin on Treatment of Pneumococcal Pneumonia in COPD and Non-COPD Patients

  3. HPLC测定复方莫西沙星滴耳液中的莫西沙星和地塞米松

    Determination of moxifloxacin hydrochloride and dexamethasone acetate in Compound moxifloxacin ear drops by HPLC

  4. 莫西沙星与左氧氟沙星治疗细菌性感染的细菌学疗效比较的Meta分析

    Meta-Analysis on Microbiological Outcomes of Bacterial Infections Treated with Moxifloxacin Versus Levofloxacin

  5. 目的研究莫西沙星在间质性肺疾病(interstitiallungdisease,ILD)治疗中用以预防性应用的可行性和有效性。

    Objective To study the feasibility and effect of Moxifloxacin in the treatment of interstitial lung disease ( ILD ) for prophylactic application .

  6. 含莫西沙星的PPI三联疗法对幽门螺杆菌根除的随机、平行对照临床研究

    Moxifloxacin-based PPI Triple-drugs Regimen for Helicobacter Pylori Eradication : A Randomized , Parallel-arm Clinic Trial

  7. 给予盐酸莫西沙星0.4g,每天1~2次,观察临床症状、肾功能及细菌学变化,评价该药的临床疗效及不良反应。

    Clinical symptoms , renal function and bacteria change were observed .

  8. 目前联盟正在与拜耳制药公司合作,检验抗生素莫西沙星(moxifloxacin)是否能用于治疗结核病。

    The alliance is working with drug company Bayer to see if the antibiotic moxifloxacin could be used to treat TB .

  9. 利福喷丁,每日量与成年人服用量相似(600mg),也单独在以莫西沙星或异烟肼为基础的DOTS疗法中试验了。

    Rifapentine , in daily amounts similar to what an adult human would take ( 600 milligrams ), was also tested separately in combination with moxifloxacin-or isoniazid-based DOTS regimens .

  10. RP-HPLC-UV法测定人血浆及痰液中的莫西沙星浓度

    Determination of moxifloxacin in human plasma and sputum by RP-HPLC-UV

  11. 科学家说,把抗生素莫西沙星(moxifloxacin)加入用于治疗结核病的标准药物组合中,可以缩短治愈患者所需的时间。

    Adding the antibiotic moxifloxacin to the standard combination of drugs currently used to treat tuberculosis ( TB ) could reduce the time needed to cure patients , researchers say .

  12. 莫西沙星以400mg·d-1的剂量,口服10d,对社区获得性肺炎有较好的治疗作用,对慢性支气管炎,只需口服5天,也有理想疗效。

    Oral moxifloxacin has a good effect in the treatment of community-acquired pneumonia ( 400mg once daily for 10 days ) and acute exacerbation of chronic bronchitis ( 400mg once daily for 5 days ) .

  13. 目的:探讨莫西沙星与左氧氟沙星治疗慢性支气管炎急性发作(AECB)的经济效果。

    Object : To explore the economic efficiency of moxifloxacin vs levofloxacin in the treatment of acute exacerbations of chronic bronchitis ( AECB ) .

  14. 方法采用前瞻性设计,将100例老年病人随机分为治疗组(52例)和对照组(48例),治疗组予莫西沙星片0.4g,po,qd,疗程14d。

    Methods A prospective design was conducted . 100 old patients with CAP were randomly divided into trial group and control group . The 52 trial group members were treated with moxifloxacin administering 0.4 g , po , qd for 14 d.

  15. 结果:莫西沙星与左氧氟沙星治疗AECB的总有效率基本相同,分别为92.00%和87.5%(P>0.05);成本-效果比分别为3.59和0.81(P<0.01)。

    Results : The effective ratios were 92.0 % and 87.5 % ( P > 0.05 ) and the cost-effect ratios were 3.59 and 0.81 for moxifloxacin and levofloxacin , respectively .

  16. 目的:观察莫西沙星短疗程治疗慢性支气管炎细菌感染急性发作(ABECB)的临床疗效。

    OBJECTIVE To compare the efficacy and safety of moxifloxacin with clarithromycin for the treatment of patients with acute bacterial exacerbations of chronic bronchitis ( ABECB ) in short course therapy .

  17. 莫西沙星治疗泌尿道感染的疗效评价

    Therapeutic Evaluation of Moxifloxacin in the Treatment of Urinary Tract Infection

  18. 氨苄青霉素和莫西沙星对流感嗜血杆菌生物被膜的抑制作用

    Inhibition of ampicillin and moxifloxacin on biofilms produced by haemophilus influenzae

  19. 122例莫西沙星所致不良反应分析

    Adverse Drug Reactions Caused by Moxifloxacin : Analysis of 122 Cases

  20. 复方莫西沙星滴耳液安全性及有效性的实验研究

    Experimental study on safety and efficacy of compound moxifloxacin ear drops

  21. 莫西沙星与多西环素治疗女性非淋菌性宫颈、尿道炎的疗效比较

    Comparison of therapeutic effects between moxifloxacin and doxycycline on non-gonococcal genito-urethritis

  22. 莫西沙星在间质性肺疾病治疗中的预防性应用

    Prophylactic Application of Moxifloxacin in the Treatment of Interstitial Lung Diseases

  23. 莫西沙星治疗沙眼衣原体宫颈炎的疗效分析双子宫天文学上的黄道第三宫

    Clinical Observation on Moxifloxacin for the Treatment of Chlamydia Trachomatis Cervicitis

  24. 莫西沙星是否符合预期仍然有待观察。

    Whether moxifloxacin will fulfil its promise remains to be seen .

  25. 莫西沙星治疗腹腔内感染的药物学研究

    Clinical Application of Moxifloxacin in the Treatment of Intra-abdominal Bacterial Infections

  26. 莫西沙星与左氧氟沙星对结核分枝杆菌的交叉耐药性研究

    Study on the cross-resistance of moxifloxacin and levofloxacin in Mycobacterium tuberculosis

  27. 含莫西沙星方案治疗复治肺结核的临床疗效观察

    The therapeutic effect of moxifloxacin in the retreatment of pulmonary tuberculosis

  28. 莫西沙星对224株凝固酶阴性葡萄球菌的体外抗菌活性观察

    In vitro antibacterial activity of moxifloxacin against 224 coagulase-negative staphylococci

  29. 莫西沙星治疗106例社区获得性肺炎病人的前瞻性研究

    Prospective study of moxifloxacin in 106 patients with community-acquired pneumonia

  30. 高效液相色谱法测定阑尾炎症组织中莫西沙星的浓度

    Determination of moxifloxacin concentration in inflammatory appendix tissue by HPLC